Monitoring New Coronavirus Variants

  • Font:
  • Ukuran Font: - +
  • illustration - A doctor holds a glass ampoule bottle containing molecular cells of the Covid-19 corona virus from England which have undergone an RNA mutation into a new variant. (ANTARA / Shutterstock / pri.)

    illustration - A doctor holds a glass ampoule bottle containing molecular cells of the Covid-19 corona virus from England which have undergone an RNA mutation into a new variant. (ANTARA / Shutterstock / pri.)

    TEMPO.COChicago - The continued spread of the Coronavirus or SARS-CoV-2 virus has spawned a Greek alphabet of variants - a naming system used by the World Health Organization (WHO) to track concerning new mutations of the virus that causes COVID-19. Some have equipped the virus with better ways of infecting humans or evading vaccine protection.

    Scientists remain focused on Delta, now the dominant variant around the world, but are tracking others to see what may one day take its place.

    Delta - Still Dominant

    The Delta variant first detected in India remains the most worrisome. It is striking unvaccinated populations in many countries and has proven capable of infecting a higher proportion of vaccinated people than its predecessors.

    The WHO classifies Delta as a variant of concern, meaning it has been shown capable of increasing transmissibility, causing more severe disease or reducing the benefit of vaccines and treatments.

    According to Shane Crotty, a virologist at the La Jolla Institute for Immunology in San Diego, Delta's "superpower" is its transmissibility. Chinese researchers found that people infected with Delta carry 1,260 times more virus in their noses compared with the original version of the coronavirus. Some U.S. research suggests that the viral load in vaccinated individuals who become infected with Delta is on par with those who are unvaccinated, but more research is needed.

    While the original coronavirus took up to seven days to cause symptoms, Delta can cause symptoms two to three days faster, giving the immune system less time to respond and mount a defense.

    Lambda - On the wane

    The Lambda variant had attracted attention as a potential new threat, but this version of the coronavirus, first identified in Peru in December, appears to be receding.

    Although cases involving Lambda were rising in July, reports of this variant have been falling globally for the past four weeks, according to data by GISAID, a database that tracks SARS-CoV-2 variants.

    The WHO classifies Lambda as a variant of interest, meaning it carries mutations suspected of causing a change in transmissibility or causing more severe disease, but it is still under investigation. Lab studies show it has mutations that resist vaccine-induced antibodies.